Literature DB >> 19755761

Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke.

Kensaku Shibazaki1, Kazumi Kimura, Yoko Okada, Yasuyuki Iguchi, Jyunichi Uemura, Yuka Terasawa, Junya Aoki.   

Abstract

BACKGROUND AND
PURPOSE: We investigated whether the plasma brain natriuretic peptide (BNP) level on admission can serve as a biological marker of in-hospital death in patients with acute ischemic stroke.
METHODS: We prospectively enrolled 335 consecutive patients (125 females; mean age, 72.3 years) with acute ischemic stroke within 24 hours of onset and measured plasma BNP on admission. Patients were divided into two groups: the deceased group, who died during hospitalization; and the survival group. The factors associated with in-hospital death were investigated by multivariate logistic regression analysis.
RESULTS: Death was observed in 20 (6.0%) patients. Frequencies of atrial fibrillation, cardioembolism, the use of diuretics before ischemic stroke, the use of digitalis before ischemic stroke, National Institutes of Health Stroke Scale (NIHSS) score on admission, glucose level, and D-dimer were significantly higher in the deceased group than in the survival group. On the other hand, albumin was significantly lower in the deceased group than in the survival group. The mean +/- SD of the plasma BNP level of the deceased group was significantly higher than that of the survival group (731.5+/-1,070.9 vs. 213.1+/-384.5 pg/mL, p=0.001). The optimal cut-off level, sensitivity, and specificity of BNP levels to distinguish the deceased group from the survival group were 240 pg/mL, 75.0% and 73.0%, respectively. Multivariate logistic regression analysis demonstrated that a NIHSS score of >13 (odds ratio [OR], 4.87; 95% confidence interval, 1.54 to 15.44, p=0.007) and plasma BNP level of >240 pg/mL (OR, 4.67; 95% confidence interval, 1.28 to 17.09, p=0.020) were independent factors associated with in-hospital death.
CONCLUSION: The plasma BNP level on admission can predict in-hospital death in patients with acute ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755761     DOI: 10.2169/internalmedicine.48.2166

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  13 in total

1.  Elevated BNP is associated with vasospasm-independent cerebral infarction following aneurysmal subarachnoid hemorrhage.

Authors:  Pam R Taub; Jeremy D Fields; Alan H B Wu; Jacob C Miss; Michael T Lawton; Wade S Smith; William L Young; Jonathan G Zaroff; Nerissa U Ko
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 2.  Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review.

Authors:  Nazeeha Hasan; Peter McColgan; Paul Bentley; Robert J Edwards; Pankaj Sharma
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

3.  Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.

Authors:  W T Longstreth; Richard A Kronmal; John L P Thompson; Robert H Christenson; Steven R Levine; Rebecca Gross; Robin L Brey; Richard Buchsbaum; Mitchell S V Elkind; David L Tirschwell; Stephen L Seliger; J P Mohr; Christopher R deFilippi
Journal:  Stroke       Date:  2013-01-22       Impact factor: 7.914

4.  N-terminal pro-brain natriuretic peptide levels and short term prognosis in acute ischemic stroke.

Authors:  Vandanapu Naveen; Bhuma Vengamma; Alladi Mohan; Velam Vanajakshamma
Journal:  Ann Indian Acad Neurol       Date:  2015 Oct-Dec       Impact factor: 1.383

5.  Experiences and the use of BNP POCT platform on suspected stroke patients by a Chinese emergency department.

Authors:  Guo Qihong; Wu Zhixin; He Mingfeng; Yang Lianhong; Xu Wenchong
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

6.  Difference in the prognostic significance of N-terminal pro-B-type natriuretic peptide between cardioembolic and noncardioembolic ischemic strokes.

Authors:  Seung-Jae Lee; Dong-Geun Lee; Dal-Soo Lim; Sukkeun Hong; Jin-Sik Park
Journal:  Dis Markers       Date:  2015-03-05       Impact factor: 3.434

Review 7.  B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis.

Authors:  Teresa García-Berrocoso; Dolors Giralt; Alejandro Bustamante; Thorleif Etgen; Jesper K Jensen; Jagdish C Sharma; Kensaku Shibazaki; Ayhan Saritas; Xingyong Chen; William N Whiteley; Joan Montaner
Journal:  Neurology       Date:  2013-11-01       Impact factor: 9.910

8.  Plasma B-type natriuretic peptide level in patients with acute cerebral infarction according to infarction subtype and infarction volume.

Authors:  Seo Hyun Kim; Ji-Yong Lee; Sang Hyun Park; Hyun-Chan Jang; Eun Ju Lim; Sei-Jin Chang; Sung-Soo Lee
Journal:  Int J Med Sci       Date:  2012-12-27       Impact factor: 3.738

9.  BNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events.

Authors:  Nicole Nigro; Karin Wildi; Christian Mueller; Philipp Schuetz; Beat Mueller; Felix Fluri; Mirjam Christ-Crain; Mira Katan
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

10.  Levels of brain natriuretic peptide as a marker for the diagnosis and prognosis of acute ischemic stroke.

Authors:  Saadet Sayan; Dilcan Kotan
Journal:  Arch Med Sci Atheroscler Dis       Date:  2016-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.